Diabetes Mellitus, Type 1
Showing NaN - NaN of 35
Diabetes, Type 1 Trial in Worldwide (insulin icodec, insulin degludec, insulin aspart)
Completed
- Diabetes Mellitus, Type 1
- insulin icodec
- +2 more
-
Concord, California
- +98 more
Feb 2, 2023
Diabetes, Type 1 Trial in Graz (NNC0363-0845, Insulin detemir)
Completed
- Diabetes Mellitus, Type 1
- NNC0363-0845
- Insulin detemir
-
Graz, AustriaNovo Nordisk Investigational Site
Nov 3, 2022
Diabetes, Type 1 Trial in Graz (NNC0471-0119 A, NNC0471-0119 B, NNC0471-0119 D)
Active, not recruiting
- Diabetes Mellitus, Type 1
- NNC0471-0119 A
- +3 more
-
Graz, AustriaNovo Nordisk Investigational Site
Aug 15, 2022
Diabetes, Type 1 Trial in Worldwide (Verapamil SR 120 mg, Placebo)
Recruiting
- Diabetes Mellitus, Type 1
- Verapamil SR 120 mg
- Placebo
-
Graz, Styria, Austria
- +22 more
Jun 29, 2022
Diabetes, Diabetes, Type 1 Trial in Worldwide (Insulin degludec, Insulin Aspart, Insulin detemir)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- Insulin degludec
- +2 more
-
Caba, Argentina
- +70 more
Mar 29, 2022
Diabetes, Type 1 Trial in Worldwide (Anti-Human Thymocyte Immunoglobulin, Rabbit)
Recruiting
- Diabetes Mellitus, Type 1
- Anti-Human Thymocyte Immunoglobulin, Rabbit
-
Graz, Austria
- +14 more
Feb 23, 2022
Diabetes, Type 1 Trial in Graz (NNC0471-0119, Fast-acting insulin aspart)
Completed
- Diabetes Mellitus, Type 1
- NNC0471-0119
- Fast-acting insulin aspart
-
Graz, AustriaNovo Nordisk Investigational Site
Jan 5, 2022
Diabetes, Type 1 Trial in Worldwide (Accu-Chek® Solo micropump system, mylife™ OmniPod® Insulin Management System, Multiple
Completed
- Diabetes Mellitus, Type 1
- Accu-Chek® Solo micropump system
- +2 more
-
Feldkirch, Austria
- +20 more
Aug 19, 2021
Hypoglycemia, Diabetes, Type 1 Trial in Worldwide (dasiglucagon, GlucaGen)
Completed
- Hypoglycemia
- Diabetes Mellitus, Type 1
-
Orlando, Florida
- +6 more
Apr 8, 2021
Diabetes, Diabetes, Type 1 Trial in Worldwide (NNC0114-0006, liraglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- NNC0114-0006
- +2 more
-
La Jolla, California
- +107 more
Mar 10, 2021
Diabetes, Type 1 Trial in Graz (NovoRapid, Fiasp, AT247)
Completed
- Diabetes Mellitus, Type 1
- NovoRapid
- +2 more
-
Graz, AustriaClinical Research Centre
Sep 27, 2019
Diabetes, Type 1, Diabetes, Type 2, Diabete Mellitus Trial in Graz, Copenhagen (Metronom CGM device)
Unknown status
- Diabetes Mellitus, Type 1
- +2 more
- Metronom CGM device
-
Graz, Austria
- +1 more
Aug 14, 2019
Diabetes, Diabetes, Type 1 Trial in Worldwide (Faster-acting insulin aspart, insulin aspart, insulin degludec)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- Faster-acting insulin aspart
- +2 more
-
Tucson, Arizona
- +151 more
May 28, 2019
Diabetes, Type 1 Trial in Graz (Insulin Peglispro, Human Insulin)
Completed
- Diabetes Mellitus, Type 1
- Insulin Peglispro
- Human Insulin
-
Graz, AustriaFor additional information regarding investigative sites for thi
Nov 6, 2018
Diabetes, Diabetes, Type 1 Trial in Graz (Faster-acting insulin aspart, insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- Faster-acting insulin aspart
- insulin aspart
-
Graz, AustriaNovo Nordisk Investigational Site
Dec 7, 2018
Diabetes, Type 1 Trial in Worldwide (Glargine, LY2605541, Insulin Lispro)
Diabetes, Diabetes, Type 1 Trial in Graz (NNC0143-0406, Insulin Aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- NNC0143-0406
- Insulin Aspart
-
Graz, AustriaNovo Nordisk Investigational Site
Feb 23, 2018
Diabetes, Diabetes, Type 1 Trial in Graz (NNC0143-0406, insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- NNC0143-0406
- insulin aspart
-
Graz, AustriaNovo Nordisk Investigational Site
Dec 5, 2017
Diabetes, Diabetes, Type 1 Trial in Graz (insulin degludec/insulin aspart, biphasic insulin aspart 30)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- insulin degludec/insulin aspart
- biphasic insulin aspart 30
-
Graz, AustriaNovo Nordisk Investigational Site
Feb 9, 2017
Diabetes, Diabetes, Type 1 Trial in Worldwide (liraglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- liraglutide
- placebo
-
Phoenix, Arizona
- +119 more
Dec 15, 2016
Diabetes, Diabetes, Type 1 Trial in Graz (liraglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- liraglutide
- placebo
-
Graz, AustriaNovo Nordisk Investigational Site
Feb 6, 2017
Diabetes, Diabetes, Type 1 Trial in Austria, Germany, South Africa (insulin detemir, insulin glargine, insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- insulin detemir
- +2 more
-
Graz, Austria
- +45 more
Jan 26, 2017
Diabetes, Diabetes, Type 1 Trial in Graz (inhaled human insulin)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- inhaled human insulin
-
Graz, AustriaNovo Nordisk Investigational Site
Jan 23, 2017
Diabetes, Diabetes, Type 1 Trial in Graz (insulin degludec)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- insulin degludec
-
Graz, AustriaNovo Nordisk Investigational Site
Jan 20, 2017